Latest Health News

Island Pharmaceuticals has won a crucial FDA Type C meeting to discuss fast-tracking its antiviral Galidesivir for Marburg virus treatment, with written feedback expected by November.

Red Hill Minerals reports a profitable FY25 with robust royalty income from the Onslow Iron Project, declaring a fully franked final dividend of 6.5 cents per share.

BCAL Diagnostics has partnered with US-based ClearNote Health to exclusively distribute innovative blood tests for early detection of pancreatic and ovarian cancers in Australia and New Zealand, starting early 2026.

Proteomics International Laboratories has achieved ISO 15189 certification for its Australian lab, marking a pivotal step in commercialising its precision diagnostic tests like PromarkerD and PromarkerEso.

Mayfield Childcare Limited has responded to ASX concerns over its half-year financial report, addressing a qualified auditor’s opinion linked to related party disclosures while confirming its financial health and ongoing ASX listing.

Mandrake Resources reports significant lithium concentrations in clastic zones of the Paradox Formation at its Utah Lithium Project, highlighting strong potential for large-scale lithium brine extraction.

PainChek’s UK pilot reveals significant clinical improvements and economic benefits, positioning the digital pain assessment app for broader adoption in Scotland and beyond.

MyEco Group has appointed Marie de Perthuis as its new CEO, aiming to leverage her extensive FMCG and retail experience to drive sales growth and build on recent operational restructuring.

Commonwealth Bank of Australia announces a fully franked dividend of AUD 1.1047 per security on its PERLS XIV capital notes for the quarter ending December 2025, with payment scheduled for mid-December.

Advanced Health Intelligence has appointed Dylan Garnett as its new CEO, signaling a strategic pivot towards commercialisation and revenue growth. Garnett’s extensive background in healthcare, insurance, and digital health positions AHI for its next growth phase.

AMP Limited has announced a quarterly distribution of AUD 1.8508 per AMP Capital Notes 2 security, payable in December 2025, reflecting a partly franked yield based on current market rates.

333D Limited has had its trading suspension lifted following a capital raise announcement and response to an ASX price query, signaling renewed market activity.